Structural basis for recognition of 2′,5′‐linked oligoadenylates by human ribonuclease L

No abstract is available for this paper.

• Publication year

  2004

• Venue

  EMBO Journal

• Publication date

  2004-10-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.emboj.7600420PMID 15385955PMCID PMC524351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Data processing.

  2021cited by this paper
• Contribution of Tyr712 and Phe716 to the activity of human RNase L.

  2004cited by this paper
• The Crystal Structure of Gankyrin, an Oncoprotein Found in Complexes with Cyclin-dependent Kinase 4, a 19 S Proteasomal ATPase Regulator, and the Tumor Suppressors Rb and p53*

  2004cited by this paper
• Designed to be stable: Crystal structure of a consensus ankyrin repeat protein

  2003influential reference
• Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.

  2003cited by this paper
• Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase.

  2003cited by this paper
• MATRAS: a program for protein 3D structure comparison

  2003cited by this paper
• Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women.

  2002cited by this paper
• Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.

  2002influential reference
• RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

  2002cited by this paper
• Crystal structure of a 12 ANK repeat stack from human ankyrinR

  2002cited by this paper
• Expression cloning

  2001cited by this paper
• Viruses and interferons.

  2001cited by this paper
• Crystal structure of the ankyrin repeat domain of Bcl‐3: a unique member of the IκB protein family

  2001cited by this paper
• Expression cloning

  2001influential reference
• IUPAC‐IUB Joint Commission on Biochemical Nomenclature Abbreviations and Symbols for the Description of Conformations of Polynucleotide Chains

  2000cited by this paper
• 2-Methyladenosine-Substituted 2',5'-oligoadenylates: conformations, 2-5A binding and catalytic activities with human ribonuclease L.

  2000cited by this paper
• The ankyrin repeat: a diversity of interactions on a common structural framework.

  1999influential reference
• Full Activation of RNaseL in Animal Cells Requires Binding of 2-5A Within Ankyrin Repeats 6 to 9 of This Interferon-Inducible Enzyme

  1999cited by this paper
• XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density.

  1999cited by this paper
• 2-Bromoadenosine-substituted 2',5'-oligoadenylates modulate binding and activation abilities of human recombinant rnase L

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998influential reference
• Structure of an IκBα/NF-κB Complex

  1998cited by this paper
• Structure of an IkBa/NF-kB Complex

  1998cited by this paper
• The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation

  1998influential reference
• How cells respond to interferons.

  1998cited by this paper
• Structure of an IkappaBalpha/NF-kappaB complex.

  1998cited by this paper
• A Bipartite Model of 2-5A-dependent RNase L*

  1997influential reference
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997influential reference
• MOLREP: an Automated Program for Molecular Replacement

  1997cited by this paper
• Stoichiometry of 2′,5′-Oligoadenylate-induced Dimerization of Ribonuclease L

  1996cited by this paper
• Expression of Platelet Glycoprotein (GP) V in Heterologous Cells and Evidence for Its Association with GP Ibα in Forming a GP Ib-IX-V Complex on the Cell Surface (*)

  1995cited by this paper
• 2-5A-dependent RNase Molecules Dimerize during Activation by 2-5A (*)

  1995cited by this paper
• The role of the dsRNA-activated kinase, PKR, in signal transduction

  1995cited by this paper
• Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.

  1994cited by this paper
• AMoRe: an automated package for molecular replacement

  1994cited by this paper
• Development of 2',5'-oligonucleotides as potential therapeutic agents

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Raster3D Version 2.0. A program for photorealistic molecular graphics.

  1994cited by this paper
• A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon.

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action.

  1993influential reference
• Automated refinement of protein models.

  1993influential reference
• 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.

  1991cited by this paper
• The Antiviral Potentials of Mx Proteins

  1991cited by this paper
• Uridine Analogs of 2', 5'-Oligoadenylates : On the Biological Role of the Middle Base of 2-5A Trimer.

  1991cited by this paper
• Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins

  1990cited by this paper
• Only one 3'-hydroxyl group of ppp5' A2'p5'A2'p5' A (2-5A) is required for activation of the 2-5A-dependent endonuclease.

  1988cited by this paper
• Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells.

  1987cited by this paper
• Commission on Biochemical Nomenclature

  1987cited by this paper
• Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L.

  1985cited by this paper
• Oligonucleotide structural parameters that influence binding of 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine to the 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine dependent endoribonuclease: chain length, phosphorylation state, and heterocyclic base.

  1984cited by this paper
• Biological activities of phosphodiester linkage isomers of 2-5A.

  1983cited by this paper
• IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Abbreviations and symbols for the description of conformations of polynucleotide chains. Recommendations 1982.

  1983cited by this paper
• Analogues and analogue inhibitors of ppp(A2'p)nA. Their stability and biological activity.

  1983cited by this paper
• Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts.

  1982cited by this paper
• Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease.

  1981cited by this paper
• Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease

  1981cited by this paper
• Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease.

  1981cited by this paper
• pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

  1978cited by this paper
• Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells

  1977cited by this paper

• Uridine as a hub in cancer metabolism and RNA biology

  2025cites this paper
• ATR&RNASEL germline variants: novel findings in a case of familial cancer

  2025cites this paper
• Sus scrofa RNase L inhibits PRRSV replication by activation of type I IFN signaling pathway and apoptosis.

  2025cites this paper
• The Interplay Between Therapeutic Self-Amplifying RNA and the Innate Immune System: Balancing Efficiency and Reactogenicity

  2025cites this paper
• crANKing up the infection: ankyrin domains in Rickettsiales and their role in host manipulation

  2024cites this paper
• Ubiquitination network in the type I IFN‐induced antiviral signaling pathway

  2023cites this paper
• Origin of the OAS–RNase L innate immune pathway before the rise of jawed vertebrates via molecular tinkering

  2023cites this paper
• Sequence and Structure-Based Analyses of Human Ankyrin Repeats

  2022cites this paper
• Gene amplification acts as a molecular foothold to facilitate cross-species adaptation and evasion of multiple antiviral pathways

  2022cites this paper
• Nucleic-Acid-Based Targeted Degradation in Drug Discovery.

  2022cites this paper
• The innate immune response during Zika virus infection

  2021cites this paper
• Genetically Modified Crops: Current Status, Prospects and Challenges Volume 2

  2021cites this paper
• Functional divergence of oligoadenylate synthetase 1 (OAS1) proteins in Tetrapods

  2021cites this paper
• Mechanisms of Attenuation by Genetic Recoding of Viruses

  2021cites this paper
• Crystal structure and functional implication of a bacterial cyclic AMP–AMP–GMP synthetase

  2021cites this paper
• GM Crops for Plant Virus Resistance: A Review

  2020cites this paper
• IFN-γ restores the impaired function of RNase L and induces mitochondria-mediated apoptosis in lung cancer

  2019cites this paper
• Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants.

  2019cites this paper
• Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations

  2019cites this paper
• Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1

  2018influential citation
• A novel mechanism of RNase L inhibition: Theiler's virus L* protein prevents 2-5A from binding to RNase L

  2018cites this paper
• The Role of Flaviviral Proteins in the Induction of Innate Immunity.

  2018cites this paper
• The Association of OASL and Type I Interferons in the Pathogenesis and Survival of Intracellular Replicating Bacterial Species

  2017cites this paper
• Detection of Regional Variation in Selection Intensity within Protein-Coding Genes Using DNA Sequence Polymorphism and Divergence

  2017cites this paper
• Engineering Resistance to Plant Viruses: Present Status and Future Prospects

  2017cites this paper
• Allosteric regulation of Csx1, a type IIIB-associated CARF domain ribonuclease by RNAs carrying a tetraadenylate tail

  2017cites this paper
• Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.

  2016cites this paper
• New advances in our understanding of the “unique” RNase L in host pathogen interaction and immune signaling

  2016cites this paper
• Role of RNase L in Inducing Autophagy and Regulating the Crosstalk from Autophagy to Apoptosis

  2015influential citation
• OASes and STING: Adaptive Evolution in Concert

  2015cites this paper
• Expression of mRNA and protein-protein interaction of the antiviral endoribonuclease RNase L in mouse spleen.

  2014cites this paper
• Can’t RIDD off viruses

  2014cites this paper
• Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity

  2014cites this paper
• Structure of Human RNase L Reveals the Basis for Regulated RNA Decay in the IFN Response

  2014cites this paper
• Recognition of 2′,5′-linked oligoadenylates by human ribonuclease L: molecular dynamics study

  2014cites this paper
• The Detection of Interaction Between Oligonucleotides and Interferon, A Key Protein of Antiviral Cell Defence System

  2014cites this paper
• Engineered plant virus resistance.

  2014cites this paper
• RNase-L Control of Cellular mRNAs: Roles in Biologic Functions and Mechanisms of Substrate Targeting

  2014cites this paper
• The Role of RNase L in Thymic Homeostasis and Humoral Responses

  2014cites this paper
• Prediction of the Repeat Domain Structures and Impact of Parkinsonism‐Associated Variations on Structure and Function of all Functional Domains of Leucine‐Rich Repeat Kinase 2 (LRRK2)

  2014cites this paper
• Synthesis of Acetylene‐Substituted Probes with Benzene‐Phosphate Backbones for RNA Labeling

  2014cites this paper
• Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.

  2013cites this paper
• Breaking New Therapeutic Grounds: Fusion Proteins of Darpins and Other Nonantibody Binding Proteins

  2013cites this paper
• Mechanistic insights into RNase L through use of an MDMX-derived multi-functional protein domain.

  2013cites this paper
• Hepatitis C virus: standard-of-care treatment.

  2013cites this paper
• Studies on interaction of oligoadenylates with proteins in vitro by MALDI-TOF mass spectrometry

  2013cites this paper
• Structural changes of human RNase L upon homodimerization investigated by Raman spectroscopy.

  2012influential citation
• Activation of human RNase L by 2'- and 5'-O-methylphosphonate-modified oligoadenylates.

  2012cites this paper
• Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations.

  2012cites this paper
• Expression, purification and characterization of the interferon-inducible, antiviral and tumour-suppressor protein, human RNase L

  2012cites this paper
• The biological regulation of ABCE1

  2012cites this paper
• Innate immune messenger 2-5A tethers human RNase L into active high-order complexes.

  2012influential citation
• Pathologic effects of RNase-L dysregulation in immunity and proliferative control.

  2012influential citation
• LRRK2: function and dysfunction Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number, and sites of Parkinson's disease mutations

  2012cites this paper
• Characterization of avian H9N2 and human 2009 pandemic influenza viruses isolated in Singapore

  2011cites this paper
• Synthesis of oligonucleotides possessing versatile probes for PET labelling and their rapid ligand-free click reaction.

  2011cites this paper
• New Insights into the Role of RNase L in Innate Immunity

  2011cites this paper
• The mode of action of the HIV protease inhibitor lopinavir against HPV

  2011cites this paper
• Inhibition of RNase L and RNA-dependent Protein Kinase (PKR) by Sunitinib Impairs Antiviral Innate Immunity*

  2011cites this paper
• The roles of large (L) gene of parainfluenza virus 5 in the host signaling pathways

  2011cites this paper
• A central role for RNA in the induction and biological activities of type 1 interferons

  2011cites this paper
• Genetic variation in RNASEL and risk for prostate cancer in a population‐based case–control study

  2011cites this paper
• An Ankyrin-repeat ubiquitin binding domain determines TRABID’s specificity for atypical ubiquitin chains

  2011cites this paper
• High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.

  2010cites this paper
• 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.

  2010cites this paper
• Turning enzymes ON with small molecules.

  2010cites this paper
• Endoribonucleases – enzymes gaining spotlight in mRNA metabolism

  2010cites this paper
• RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.

  2010cites this paper
• Studies on HIF hydroxylases

  2008cites this paper
• La RNase L, un acteur essentiel de la réponse cellulaire antivirale

  2008cites this paper
• [RNase L, a crucial mediator of innate immunity and other cell functions].

  2008cites this paper
• A primer on ankyrin repeat function in TRP channels and beyond.

  2008cites this paper
• A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.

  2008cites this paper
• Germline Mutation in RNASEL Predicts Increased Risk of Head and Neck, Uterine Cervix and Breast Cancer

  2008cites this paper
• Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes

  2007cites this paper
• Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.

  2007cites this paper
• Diverse functions of RNase L and implications in pathology.

  2007influential citation
• A scientific journey through the 2-5A/RNase L system.

  2007cites this paper
• Interferon-based therapy of hepatitis C.

  2007cites this paper
• [Structural and functional studies on proteins as potential drug discovery targets].

  2007cites this paper
• A Phylogenetically Conserved RNA Structure in the Poliovirus Open Reading Frame Inhibits the Antiviral Endoribonuclease RNase L

  2007cites this paper
• A new RNA branching activity: the GIR1 ribozyme.

  2007cites this paper
• Biologically Stable 2‐5A Analogues containing 3′‐O,4′‐C‐bridged Adenosine as Potent RNase L Agonists

  2007cites this paper
• Rapid Detection of Positive Selection in Genes and Genomes Through Variation Clusters

  2007cites this paper
• Viral Encounters with 2′,5′-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response

  2007cites this paper
• DARPins: a true alternative to antibodies.

  2007cites this paper
• Small-molecule activators of RNase L with broad-spectrum antiviral activity

  2007cites this paper
• Composes se liant a l'antigene membranaire specifique de la prostate (psma) et utilisations associees

  2006cites this paper
• RNase L: Its biological roles and regulation

  2006cites this paper
• An Alternative Spliced RNASEL Variant in Peripheral Blood Leukocytes

  2006cites this paper
• Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates.

  2006cites this paper
• [Activation mechanism of an anti-viral ribonuclease, RNase L].

  2006cites this paper
• Mapping of the Human RNASEL Promoter and Expression in Cancer and Normal Cells

  2005cites this paper
• 2‐5A induces a conformational change in the ankyrin‐repeat domain of RNase L

  2005cites this paper
• Functional Characterization of 2′,5′-Linked Oligoadenylate Binding Determinant of Human RNase L*

  2005cites this paper
• 2',5'-結合オリゴアデニル酸はリボヌクレアーゼLのN末端ドメインに結合する

  2005cites this paper
• EngagedScholarship@CSU EngagedScholarship@CSU

  year unknowncites this paper
• International Journal of Molecular Sciences the Roles of Rnase-l in Antimicrobial Immunity and the Cytoskeleton-associated Innate Response

  year unknowncites this paper